Source:http://linkedlifedata.com/resource/pubmed/id/11839252
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5-6
|
pubmed:dateCreated |
2002-2-12
|
pubmed:abstractText |
We have previously shown that the normal adult colon produces a sialomucin containing the core trisaccharide 1,3 N-acetylgalactosamine. This structure was shown to be the epitope for a polyclonal antiserum that demonstrated colon "specific" activity. Antiserum binding is dependent upon the presence of O-acetylated sialic acids present at high concentrations in normal adult colon tissue. However, O-acetylation of sialic acids is decreased in colorectal cancer. Indeed, approximately 50% of colorectal carcinomas are nonreactive with this antiserum. In the current work, we used a de-O-acetylated, normal colon mucin as immunogen to generate monoclonal antibody (MAb) G47. Untreated normal colon mucins having a high O-acetylated sialic acid content were essentially nonreactive with G47. Removal of O-acetyl groups by saponification generated a reactive mucin derivative while subsequent treatment with neuraminidase abolished reactivity. By immunoperoxidase procedures MAb-G47 was reactive with approximately 85% of colorectal tumors while exhibiting relatively low reactivity with normal colon tissue. Mucins isolated from normal colon had on average less than 10% of the specific epitope as compared with mucins derived from colorectal tumors (p < 0.01). Initial immunohistochemical studies on tumors of noncolonic origin revealed few positive cases. The potential of MAb-G47 to assist in the diagnosis and/or prognosis of colorectal cancer is now being studied.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Mucins,
http://linkedlifedata.com/resource/pubmed/chemical/Sialomucins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1536-8599
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
343-50
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11839252-Animals,
pubmed-meshheading:11839252-Antibodies, Monoclonal,
pubmed-meshheading:11839252-Antibody Specificity,
pubmed-meshheading:11839252-Antigen-Antibody Reactions,
pubmed-meshheading:11839252-Antigens, Neoplasm,
pubmed-meshheading:11839252-Antigens, Surface,
pubmed-meshheading:11839252-Colorectal Neoplasms,
pubmed-meshheading:11839252-Humans,
pubmed-meshheading:11839252-Hybridomas,
pubmed-meshheading:11839252-Immunohistochemistry,
pubmed-meshheading:11839252-Mice,
pubmed-meshheading:11839252-Mice, Inbred BALB C,
pubmed-meshheading:11839252-Mucins,
pubmed-meshheading:11839252-Sialomucins
|
pubmed:year |
2001
|
pubmed:articleTitle |
Monoclonal antibody G47 engineered to be reactive with colorectal tumor mucin.
|
pubmed:affiliation |
The Garden State Cancer Center, 520 Belleville Avenue, Belleville, NJ 07109, USA. dvgold@att.net
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|